Chemokine Receptor Expression on the Surface of Peripheral Blood Mononuclear Cells in Chagas Disease

Journal of Infectious Diseases

Volumn 189, Issue 2, 2004, Pages 214-220

  Talvani, Andre ^a   Rocha, Manoel O C ^c   Ribeiro, Antonio L ^b   Correa Oliveira, Rodrigo ^c   Teixeira, Mauro M ^a,b,c  

^a Instituto de Ciencias Biologicas   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4;

ADULT; ARTICLE; CELL SURFACE; CHAGAS DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE SEVERITY; FEMALE; HEART VENTRICLE FUNCTION; HUMAN; HUMAN CELL; LEUKOCYTE; MALE; PARASITOSIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRYPANOSOMA CRUZI;

CHAGAS CARDIOMYOPATHY; CHRONIC DISEASE; FEMALE; HEART; HUMANS; LEUKOCYTES, MONONUCLEAR; MALE; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; RECEPTORS, CXCR4;

EID: 0742307348     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/380803     Document Type: Article

References (27)

1. Rocha MOC, Ribeiro AL, Teixeira MM. Clinical management of chronic Chagas cardiomyopathy. Frontiers Biosci 2003; 8:e44-54.
2. Prata A. Clinical and epidemiological aspects of Chagas disease. Lancet Infect Dis 2001; 1:92-100.
3. Higuchi ML, Gutierrez PS, Aiello VD. Immunohistochemical characterization of infiltrating cells in human chronic chagasic myocarditis: comparison with myocardial rejection process. Virchows Arch A Pathol Anat Histopathol 1993; 423:157-60.
4. + T cell dependent. Am J Trop Med Hyg 1997; 56:485-9.
5. Cunha-Neto E, Kalil J. Molecular mimicry and Chagas' disease. In: Cunningham MW, Fujinami RS, eds. Molecular mimicry, microbes, and autoimmunity. Washington, DC: ASM Press, 2000:257-3.
6. Cunha-Neto E, Kalil J. Heart-infiltrating and peripheral T cells in the pathogenesis of human Chagas' disease cardiomyopathy. Autoimmunity 2001; 34:187-92.
7. Teixeira MM, Gazzinelli RT, Silva JS. Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 2002; 18:262-65.
8. Proudfoot AEI. Chemokine receptors: multifaceted therapeutic targets. Nat Rev Immunol 2002; 2:106-15.
9. Petray P, Corral R, Meckert P, et al. Role of macrophage inflammatory protein-1alpha (MIP-1alpha) in macrophage homing in the spleen and heart pathology during experimental infection with Trypanosoma cruzi. Acta Trop 2002; 83:205-11.
10. Machado FS, Martins GA, Aliberti JC, et al. Trypanosoma cruzi-infected cardiomyocytes produce chemokines and cytokines that trigger potent nitric oxid-dependent trypanocidal activity. Circulation 2000; 102:3003-8.
11. Talvani A, Ribeiro CS, Aliberti JC, et al. Kinetics of cytokine gene expression in experimental chagasic cardiomyopathy: tissue parasitism and endogenous IFN-gamma as important determinants of chemokine mRNA expression during infection with Trypanosoma cruzi. Microbes Infect 2000; 2:851-66.
12. Villalta F, Zhang Y, Bibb KE, et al. The cysteine-cysteine family of chemokine RANTES, MIP-1α, MIP-1β induce trypanocidal activity in human macrophages via nitric oxide. Infect Immun 1998; 66:4690-5.
13. Aliberti JC, Souto JT, Marino AP, et al. Modulation of chemokine production and inflammatory responses in interferon-gamma- and tumor necrosis factor-R-1-deficient mice during Trypanosoma cruzi infection. Am J Pathol 2001; 158:1433-40.
14. Coelho PS, Klein A, Talvani A, et al. Glycosylphosphatidylinositol- anchored mucin-like glycoproteins isolated from Trypanosoma cruzi trypomastigotes induce leukocyte recruitment in vivo. J Leukocyte Biol 2002; 71:837-44.
15. Calzada JE, Nieto A, Beraun Y, et al. Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy. Tissue Antigens 2001; 58:154-8.
16. Damas, JK, Eiken HG, Oie H, et al. Myocardial expressing of CC- and CXC-chemokines and their receptors in human end-stage heart failure. Cardiovasc Res 2000; 47:778-87.
17. Damas JK, Gullestad L, Aass H, et al. Enhanced gene expression of chemokines and their corresponding receptors in mononuclear blood cells in chronic heart failure - modulatory effect of intravenous immunoglobulin. J Am Coll Cardiol 2001; 38:187-93.
18. Aukrust P, Damas JK, Gullestad L, Froland SS. Chemokines in myocardial failure - pathogenic importance and potential therapeutic targets. Clin Exp Immunol 2001; 124:343-5.
19. Filippatos G, Parissis JT, Adamopoulos S, Kardaras F. Chemokines in cardiovascular remodeling: clinical and therapeutic implications. Curr Mol Med 2003; 3:139-47.
20. Ortlepp JR, Vesper K, Mevissen V, et al. Chemokine receptor (CCR2) genotype is associated with myocardial infarction and heart failure in patients under 65 years of age. J Mol Med 2003; 81:363-7.
21. Aliberti JC, Machado FS, Souto JT, et al. β-chemokines enhance parasite uptake and promote nitric oxide-dependent microbiostatic activity in murine inflammatory macrophages infected with Trypanosoma cruzi. Infect Immun 1999; 67:4819-22.
22. Barros MV, Ribeiro AL, Machado FS. Doppler tissue imaging to assess systolic function in Chagas disease. Arq Bras Cardiol 2003; 80:36-40.
23. Froelicher VF, Myers J. Exercise and the heart. 4th ed. Philadelphia: Saunders, 2000
24. Petkova SB, Huang H, Factor SM, et al. The role of endothelin in the pathogenesis of Chagas' disease. Int J Parasitol 2001; 31:499-511.
25. +alpha beta T cells in Trypanosoma cruzi-elicited myocarditis is associated with acquisition of CD62L(Low)LFA-1(High)VLA-4(High) activation phenotype and expression of IFN-gamma-inducible adhesion and chemoattractant molecules. Microbes Infect 2001; 3:971-84.
26. + lymphocytes. Am J Trop Med Hyg 1993; 48:637-44.
27. + T-cell line obtained from a chronic chagasic mouse induces carditis in heart-immunized mice and rejection of normal heart transplants in the absence of Trypanosoma cruzi. Parasite Immunol 2001; 23:93-101.